PP-8 OXMINT - 2 years of data from the oxford metastatic intervention team

Read full text
Authors: Jennifer Paskins, Yaron J. Berkowitz, Jeremy J. Reynolds, Euan Stirling, Gerard Mawhinney, Alex Anderson, Nicolas Beresford-Cleary, ATHER SIDDIQI, Muhammed Riaz, Emma Kenny-Herbert, Hayley Jones, James The
+2 more Victoria Bradley, Clare Jacobs
Cited by: 0

Abstract

Introduction Local data suggests 20-27% of patients known to the OUH Palliative Care Service have metastatic bone disease. Literature calls for a Multi-Disciplinary approach to support and co-ordinate care in patients with metastatic bone disease but there is no clear definition of what components the team should entail. Until 2023 there had been no clear established pathway for referral, discussion and management of symptomatic bone metastases in Oxfordshire. This had led to a fragmented and inequitable service for patients with management plans often guided by individual clinician experience or network Aims OxMINT (Oxford Metastatic Intervention Team) is a novel and innovative service to provide a safe and effective clinical forum to support the ever-growing patient population with metastatic spinal disease. Methods The service was designed and implemented by Dr Victoria Bradley, Clinical Lead for and Consultant in Palliative Medicine in 2023. The goal is to focus on managing symptoms, maintaining functional status and quality of life with expert input from; Orthopaedics (general and spine), Radiology including interventional radiology, Interventional pain (anaesthetics), Clinical Oncology, Palliative Medicine, Neurosurgery and Psychological Medicine Results The OxMINT service has now reviewed over 300 patients with an intervention rate of 76% and re-discussion rate of 4.6%. 75% of patients undergo active intervention (Radiotherapy, Interventional radiology or Surgery). On follow-up, a major and sustainable improvement is seen in pain, function and dependence on controlled drugs for pain relief. 2 year follow-up has indicated a low complication rate and appropriate MDT clinical recommendation in line with patients’ prognoses. Conclusion Specialist MDT for Patients with metastatic bone disease can improve pain and function for those who undergo active intervention. Impact 300% increase in the number of patients seen by the metastatic spinal surgery team Patients are able to prolong preservation function and quality of life with OxMINT

Fields of Study & Subjects

Management of metastatic bone disease Pain Management and Opioid Use Bone health and treatments

Publication details

Journal / source
BMJ Supportive & Palliative Care
Pages
A9.1–A9
Publication date
22 February 2026
Language
EN